Corteva, Inc.
CTVA · NYSE
CTVA · NYSE
Corteva sells seed technologies and crop-protection products, and also earns licensing income. Its results are driven by seed pricing and productivity, demand for newer crop-protection products, seed volumes, competitive pricing, and cost discipline. The available evidence does not provide a segment revenue split, customer breakdown, geography, or headcount, so those aspects cannot be quantified here. Corteva reported FY2025 revenue of $17.4 billion and net income of $1.1 billion, up from $16.9 billion and $0.9 billion, respectively, in FY2024. That is the company’s reported financial scale in the supplied data.
Corteva fell $10.64, or 11.96%, from $88.95 to $78.31 over the period. The stock initially rose to $90.51 on July 29 before slipping to $89.34 on July 30, then dropped sharply to $78.71 on July 31 on heavy volume following its second-quarter report. The results delivered an EPS beat and a raised 2026 outlook, but sales fell 1% and profit declined as reduced seed volumes and competitive crop-protection pricing weighed on performance. Shares continued lower to $76.04 on August 3, then recovered to $78.31 on August 4, regaining only part of the post-earnings decline. No broader market driver is identified in the supplied evidence.
